Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PepGen Inc. - Common Stock (NQ: PEPG )

16.37 -0.63 (-3.69%)
Streaming Delayed Price Updated: 3:50 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,775
Open 18.23
Bid (Size) 16.35 (1)
Ask (Size) 16.67 (2)
Prev. Close 17.00
Today's Range 16.35 - 18.35
52wk Range 4.320 - 17.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
PepGen to Host Fourth Quarter and Full Year 2022 Financial Results Call
From PepGen Inc.
Via Globe NewsWire
PepGen Announces Upcoming Data Presentations at the 2023 Annual Muscle Dystrophy Association Clinical and Scientific Conference
From PepGen Inc.
Via Globe NewsWire

Performance

YTD
+22.82%
+22.82%
1 Month
-1.55%
-1.55%
3 Month
+12.84%
+12.84%
6 Month
+214.25%
+214.25%
1 Year
+27.02%
+27.02%

More News

Read More
PepGen to Participate in the SVB Securities Global Biopharma Conference
From PepGen Inc.
Via Globe NewsWire
Why This PepGen Analyst Is Bullish On The Biotech Stock
Via Benzinga
Around $12M Bet On This Technology Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Via Benzinga
PepGen Announces IND-Enabling Preclinical Data Supporting Progression of PGN-EDODM1 into Clinical Studies
From PepGen Inc.
Via Globe NewsWire
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Hillenbrand, Cisco, Macy's And Other Big Gainers From Thursday
Via Benzinga
PepGen Announces Positive Preclinical Data for PGN-EDO53, PGN-EDO45 and PGN-EDO44, Three Novel Duchenne Muscular Dystrophy Candidates
From PepGen, Inc
Via Globe NewsWire
PepGen Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
From PepGen, Inc
Via Globe NewsWire
PepGen to Participate in the Stifel 2022 Healthcare Conference
From PepGen, Inc
Via Globe NewsWire
PepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress
From PepGen, Inc
Via Globe NewsWire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Tesla, Altus Power And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
Via Benzinga
Nasdaq Surges Over 150 Points; Gold Rises 2%
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
PepGen (NASDAQ: PEPG) Shares Phase 1 Clinical Trial Results of PGN-EDO51 Showing Positive Data in Treating Duchenne Muscular Dystrophy
Via Spotlight Growth
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.